TO
Tuyen Ong
CEO at Ring Therapeutics
TO
Tuyen Ong
CEO at Ring Therapeutics
Cambridge, Massachusetts
Overview
Work Experience
Chief Executive Officer
2020 - Current
CEO partner
2020
Member Board of Directors
2022
Board of Advisors
2017
Board of Directors
2020 - 2022
SVP, Head of Ophthalmology Franchise
2019 - 2020
EVP, Chief Development Officer
2017 - 2019
Nightstar Therapeutics (Acquired by Biogen in June 2019)
Chief Medical Officer
2014 - 2017
SVP, Head of Clinical and Research Development (2014-2016)
VP, Clinical Development and Operations
2010 - 2014
Executive Director, Head of Clinical and Scientific Affairs (2010 -2013)
Global Clinical Lead
2005 - 2010